Kurt F. Hauser, Ph.D.
|Pharmacology & Toxicology||Virginia Commonwealth University School of Medicine, Richmond, VA|
Area:Neuropharmacology, NeuroAIDS, Substance abuse, Glia
Google:"Kurt F Hauser"
Mean distance: 17.79 (cluster 32)
Cross-listing: Chemistry Tree
ParentsSign in to add mentor
ChildrenSign in to add trainee
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Leibrand CR, Paris JJ, Jones AM, et al. (2022) Independent actions by HIV-1 Tat and morphine to increase recruitment of monocyte-derived macrophages into the brain in a region-specific manner. Neuroscience Letters. 136852|
|Lark ARS, Silva LK, Nass SR, et al. (2022) Progressive Degeneration and Adaptive Excitability in Dopamine D1 and D2 Receptor-Expressing Striatal Neurons Exposed to HIV-1 Tat and Morphine. Cellular and Molecular Neurobiology|
|Nass SR, Ohene-Nyako M, Hahn YK, et al. (2022) Neurodegeneration Within the Amygdala Is Differentially Induced by Opioid and HIV-1 Tat Exposure. Frontiers in Neuroscience. 16: 804774|
|McLane VD, Lark ARS, Nass SR, et al. (2022) HIV-1 Tat reduces apical dendritic spine density throughout the trisynaptic pathway in the hippocampus of male transgenic mice. Neuroscience Letters. 782: 136688|
|Yarotskyy V, Lark ARS, Nass SR, et al. (2022) Chloride channels with CLC-1-like properties differentially regulate the excitability of dopamine receptor D1- and D2-expressing striatal medium spiny neurons. American Journal of Physiology. Cell Physiology|
|Barbour AJ, Nass SR, Hahn YK, et al. (2021) Restoration of KCC2 Membrane Localization in Striatal Dopamine D2 Receptor-Expressing Medium Spiny Neurons Rescues Locomotor Deficits in HIV Tat-Transgenic Mice. Asn Neuro. 13: 17590914211022089|
|Nass SR, Lark ARS, Hahn YK, et al. (2021) HIV-1 Tat and morphine decrease murine inter-male social interactions and associated oxytocin levels in the prefrontal cortex, amygdala, and hypothalamic paraventricular nucleus. Hormones and Behavior. 133: 105008|
|Huang B, Wang H, Zheng Y, et al. (2021) Structure-Based Design and Development of Chemical Probes Targeting Putative MOR-CCR5 Heterodimers to Inhibit Opioid Exacerbated HIV-1 Infectivity. Journal of Medicinal Chemistry|
|Marks WD, Paris JJ, Barbour AJ, et al. (2021) HIV-1 Tat and morphine differentially disrupt pyramidal cell structure and function and spatial learning in hippocampal area CA1: Continuous versus interrupted morphine exposure. Eneuro|
|Ma H, Wang H, Li M, et al. (2020) Bivalent Ligand Aiming Putative Mu Opioid Receptor and Chemokine Receptor CXCR4 Dimers in Opioid Enhanced HIV-1 Entry. Acs Medicinal Chemistry Letters. 11: 2318-2324|